Hester Biosciences Q2 net profit up 39 pc at Rs 6 cr

Drug firm Hester Biosciences today reported a 38.92 per cent rise in its standalone net profit to Rs 5.96 crore for the second quarter ended September 30.
The company had posted a net profit of Rs 4.29 crore for the corresponding period of the previous fiscal, Hester Biosciences said in a BSE filing.
Standalone net sales of the company also rose to Rs 29.63 crore for the quarter under review as against Rs 24 crore for the same period last fiscal.
Nepal plant of the company is slated to commence commercial production on November 15, 2016, Hester Biosciences said.
In a separate filing, the company said its board has declared an interim dividend of 30 per cent, Rs 3 per equity share on the face value of Rs 10 per share for the financial year 2016-17.

Shares of Hester Biosciences were trading 1.71 per cent down at Rs 754 on BSE.